Why the study?
Pulmonary embolism is a life-threatening disease where risk stratification can guide clinical decisions, patient disposition, and treatment.
Risk stratification in acute pulmonary embolism is crucial for optimizing patient disposition and tailoring treatment to reduce mortality and bleeding risks.
No takes yet. Share an insight, caveat, or question.
Review synthesizes PE risk tools; reinforces guidelines while leaving optimal model selection open.
Maraziti et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: